Skip to content

Facebook Twitter Linkedin

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Menu

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Investor Relations

Latest News

InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update

September 29, 2023

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

September 22, 2023

InMed to Present at H.C. Wainwright 25th Annual Global Investment Conference

September 7, 2023

InMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ET

July 21, 2023

View More News

Latest Events

Benzinga Cannabis Capital Conference

Sept. 27-28, 2023

H.C. Wainwright 25th Annual Global Investment Conference

Sept. 11-13, 2023

Investor Summit

June 1, 2023

Tribe Public Webinar

May 31, 2023

View More Events

Stock Information

NASDAQ:INM stock price by TradingView

See Stock Information

Analyst Coverage

Robert Sassoon

Water Tower Research LLC
[email protected]
516 668 3632

Presentations

Corporate Presentation – September 2023

View Presentation

View All Presentations

Latest Financial Reports

2023

Q1

Quarterly Press Release

10-Q

Q2

Quarterly Press Release

Financial Statements

MD&A

Q3

Quarterly Press Release

Financial Statements

MD&A

View All Financial Reports

Latest SEC Filings

Investor Alerts

Sign up for investor alerts!

Information Request

Send us a request for information

#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Pharmaceutical

Cannabinoids in Development
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
INM-900 Series for Neurodegenerative Disease
Novel Cannabinoid Analogs

MANUFACTURING

BayMedica – Rare Cannabinoid Ingredients
Cannabinoid Manufacturing Expertise
IntegraSyn™ Cannabinoid Manufacturing

Investor

News
Events
Stock Information
Corporate Governance
Financials & AGM Materials
Filings
Presentations
Media & Videos
Investor Contact

CORPORATE

Management
Board of Directors
Scientific Advisors
Partners and Collaborators
Careers
Contact

Learn

What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabinoids for Glaucoma
Cannabinoid Science
Articles and Videos

© Copyright 2023 InMed Pharmaceuticals Inc.

Privacy Policy
Terms of Use
Legal Disclaimer

Find Us On:

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*

First name* Last name*

Email*

Consent*

By providing your e-mail address, you consent to receive news, press releases, quarterly and annual reports, presentations and other information from InMed Pharmaceuticals Inc. You can unsubscribe at any time.

CAPTCHA